Nonalcoholic Fatty Liver Disease [dsyn]    
Women [popg]    
Polycystic Ovary Syndrome [dsyn]    
Aims [idcn]    
INSULIN RESISTANCE [patf]    
pathogenesis [ftcn]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Polycystic Ovary Syndrome [dsyn]    
Nonalcoholic Fatty Liver Disease [dsyn]    
OBESE [dsyn]    
Women [popg]    
Polycystic Ovary Syndrome [dsyn]    
Study [mnob]    
Estimate [qnco]    
hepatic steatosis [dsyn]    
Women [popg]    
Polycystic Ovary Syndrome [dsyn]    
Methods [inpr]    
Retrospective Study [resa]    
Consecutive [qlco]    
Premenopausal [tmco]    
Women [popg]    
Polycystic Ovary Syndrome [dsyn]    
History [ocdi]    
Height [orga]    
Weight [orga]    
Values [qlco]    
Obtained [ftcn]    
FASTING [fndg]    
measurements [ftcn]    
Serum Glucose [lbpr]    
Calculate [acty]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
Abdominal [blor]    
Ultrasonography [diap]    
Severity [qlco]    
hepatic steatosis [dsyn]    
Women [popg]    
Median [spco]    
YEARS [tmco]    
Steatosis [patf]    
Women [popg]    
Steatosis [patf]    
Greater [qnco]    
Body mass index [diap]    
Homeostatic Model Assessment of Insulin Resistance [lbpr]    
LOWER [spco]    
FASTING [fndg]    
Greater [qnco]    
Impaired fasting glucose [fndg]    
Impaired glucose tolerance [dsyn]    
DIABETES MELLITUS [dsyn]    
Subject [grup]    
hepatic steatosis [dsyn]    
abnormal liver [fndg]    
Chemistry [ocdi]    
Conclusions [idcn]    
FATTY LIVER [dsyn]    
Identified [qlco]    
Subject [grup]    
Polycystic Ovary Syndrome [dsyn]    
Nearly [qlco]    
Women [popg]    
Body mass index [diap]    
INSULIN RESISTANCE [patf]    
APPEAR [qlco]    
Important [qlco]    
Recognition [menp]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Group [idcn]    
Young [tmco]    
Patients [podg]    
Investigation [hlca]    
Including [ftcn]    
Liver Biopsy [diap]    
Indicated [fndg]    
